UNICA IRIS Institutional Research Information System

PISANU, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 154.720
NA - Nord America 9.301
AS - Asia 4.775
SA - Sud America 1.012
Continente sconosciuto - Info sul continente non disponibili 636
AF - Africa 175
OC - Oceania 42
Totale 170.661
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.306
US - Stati Uniti d'America 9.006
SG - Singapore 1.859
CN - Cina 1.364
BR - Brasile 770
SE - Svezia 550
VN - Vietnam 509
DE - Germania 336
GB - Regno Unito 332
FR - Francia 234
FI - Finlandia 228
HK - Hong Kong 210
NL - Olanda 191
CA - Canada 166
BD - Bangladesh 149
IN - India 137
UA - Ucraina 135
AR - Argentina 95
KR - Corea 80
ES - Italia 77
MX - Messico 69
JP - Giappone 68
AT - Austria 53
IQ - Iraq 53
PL - Polonia 49
TR - Turchia 48
ZA - Sudafrica 47
MA - Marocco 45
EC - Ecuador 42
AU - Australia 38
RU - Federazione Russa 37
BE - Belgio 36
CO - Colombia 29
PK - Pakistan 29
ID - Indonesia 24
NO - Norvegia 24
PH - Filippine 24
SA - Arabia Saudita 23
VE - Venezuela 23
IE - Irlanda 22
UZ - Uzbekistan 22
IR - Iran 21
CL - Cile 19
MY - Malesia 19
DK - Danimarca 18
CZ - Repubblica Ceca 17
JO - Giordania 17
JM - Giamaica 16
EG - Egitto 14
KE - Kenya 14
IL - Israele 13
KZ - Kazakistan 13
PY - Paraguay 13
CH - Svizzera 12
TW - Taiwan 12
AE - Emirati Arabi Uniti 11
PT - Portogallo 11
TN - Tunisia 11
DZ - Algeria 10
LT - Lituania 10
AZ - Azerbaigian 9
NI - Nicaragua 7
OM - Oman 7
PS - Palestinian Territory 7
BO - Bolivia 6
GT - Guatemala 6
KG - Kirghizistan 6
NP - Nepal 6
PA - Panama 6
PE - Perù 6
SN - Senegal 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GE - Georgia 5
MD - Moldavia 5
QA - Qatar 5
RS - Serbia 5
AM - Armenia 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
NZ - Nuova Zelanda 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
RO - Romania 3
TT - Trinidad e Tobago 3
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
IS - Islanda 2
LV - Lettonia 2
Totale 169.986
Salva come PNG Salva come JPEG
Città #
Cagliari 147.157
Uta 4.411
Singapore 981
Ashburn 970
Dallas 787
Fairfield 721
San Jose 664
Chandler 379
Boardman 352
New York 341
Woodbridge 340
Houston 326
Seattle 290
Nyköping 260
Beijing 258
Los Angeles 241
Cambridge 221
Wilmington 221
Council Bluffs 208
Hong Kong 182
Ann Arbor 178
Santa Clara 174
The Dalles 164
Helsinki 146
Ho Chi Minh City 144
Hefei 124
Shanghai 123
Lauterbourg 112
Boston 107
Hanoi 106
Dearborn 88
Rome 85
São Paulo 81
Seoul 75
Jacksonville 72
Buffalo 71
Munich 70
Cardiff 61
Dong Ket 60
Orem 58
Tokyo 57
Chicago 55
Nieuwegein 54
Montreal 52
Frankfurt am Main 50
Atlanta 48
Nuremberg 44
London 43
Milan 43
San Diego 42
Warsaw 39
Lappeenranta 38
Redondo Beach 38
Johannesburg 36
Nanjing 35
Denver 34
Amsterdam 33
Brooklyn 32
Brussels 32
Toronto 32
Vienna 30
Casablanca 29
Chennai 29
Poplar 29
San Francisco 28
Stockholm 28
Redwood City 27
Guangzhou 26
Phoenix 26
Mexico City 25
Rio de Janeiro 25
Da Nang 22
Oslo 22
Tianjin 22
Turku 22
Norwalk 21
Haiphong 19
Changsha 18
Tashkent 18
Aurora 17
Baghdad 17
Manchester 17
Nanchang 17
Naples 17
Rotterdam 17
Belo Horizonte 16
Guayaquil 16
Paris 16
Shenyang 16
Shenzhen 16
Ankara 15
Quito 15
Swansea 15
Amman 14
Biên Hòa 14
Brasília 14
City of London 14
Dublin 14
Hangzhou 14
Pune 14
Totale 163.037
Salva come PNG Salva come JPEG
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.377
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.268
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein 3.697
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.631
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.579
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.514
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.429
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.152
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.051
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.051
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.022
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.013
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.991
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.900
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.890
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.826
Involvement of core clock genes in lithium response 2.819
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.713
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.678
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.678
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.670
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.653
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.602
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis 2.578
Prediction of Lithium Response using Clinical Data 2.491
High leptin levels are associated with migraine with aura 2.474
Pharmacogenomics of bipolar disorder 2.407
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.382
Lithium pharmacogenetics: Where do we stand? 2.289
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.233
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.192
null 2.132
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 2.113
Characterisation of age and polarity at onset in bipolar disorder 2.029
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.009
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica 1.991
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.941
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.891
Lithium pharmacogenetics 1.862
A genetic risk score is differentially associated with migraine with and without aura 1.853
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.730
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.677
Leukocyte telomere length is reduced in patients with major depressive disorder 1.666
Prediction of lithium response using genomic data 1.656
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.639
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.610
null 1.572
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.519
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.505
PharmacoloGenius: Development of a mobile application to engage in pharmacology 1.477
Telomere length in bipolar disorder and lithium response 1.310
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.275
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.266
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.233
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.203
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.191
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants 1.191
Assessment of the pharmacogenomics educational environment in southeast europe 1.185
null 1.156
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.020
A genome-wide association study of antidepressant-induced mania 992
Gender Differences among Sardinians with Alcohol Use Disorder 952
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 829
Sex differences in alcohol use disorder 823
The Xs and Y response to opioids in acute and chronic pain 805
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis 796
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 790
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 781
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 778
Sex differences in substance use disorders: focus on side effects 775
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 769
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank 735
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 730
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 722
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 722
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 713
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder 712
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 677
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 666
Effect of Lithium on gene expression modulation 666
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 660
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 653
Genetic and Epigenetic Markers of Lithium Response 646
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 645
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 642
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders 597
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 585
An analysis-ready and quality controlled resource for pediatric brain white-matter research 555
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study 555
Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014 506
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 504
Towards precision medicine in psychiatry: investigating the contribution of cellular aging, pleiotropy and gender differences in psychiatric disorders and pharmacological response 491
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis 484
New insights into the genetic etiology of Alzheimer's disease and related dementias 481
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 478
Plasma stearoyl-coA desaturase activity indices and bile acid concentrations after a low-fat meal: Association with a genetic variant in the FTO gene 452
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept 445
NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition 422
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 421
Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28) 399
Totale 163.206
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229.549 0 652 510 1.016 990 707 574 508 1.262 1.197 1.204 929
2022/202316.802 960 2.313 2.452 1.529 1.304 1.617 848 1.042 1.211 1.248 1.470 808
2023/202416.375 770 611 612 1.037 1.419 2.565 2.311 1.197 835 1.075 1.958 1.985
2024/202538.024 10.322 11.152 3.920 3.963 2.061 2.347 2.445 163 396 410 319 526
2025/202612.172 940 614 1.489 1.289 1.019 879 1.742 1.012 754 1.393 730 311
2026/2027415 312 103 0 0 0 0 0 0 0 0 0 0
Totale 170.661